Upregulation of Trefoil Factor 3 (TFF3) After Rectal Cancer Chemoradiotherapy Is an Adverse Prognostic Factor and a Potential Therapeutic TargetEnrique Casado, Paloma Cejas, Jaime Feliú et al.|International Journal of Radiation Oncology*Biology*Physics|2012Cited by 23
62P A multi-center real-world study of the efficacy and safety of PARP inhibitors in patients with ovarian cancer in SpainRodrigo Sánchez-Bayona, Ainhoa Madariaga, C. Maximiano Alonso et al.|ESMO Open|2024Cited by 0